BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30777214)

  • 21. Hypofractionated accelerated computed tomography-guided interstitial high-dose-rate brachytherapy for liver malignancies.
    Tselis N; Chatzikonstantinou G; Kolotas C; Milickovic N; Baltas D; Chung TL; Zamboglou N
    Brachytherapy; 2012; 11(6):507-14. PubMed ID: 22571828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.
    Yoon SM; Suh R; Abtin F; Moghanaki D; Genshaft S; Kamrava M; Drakaki A; Liu S; Venkat P; Lee A; Chang AJ
    Radiat Oncol; 2021 Jun; 16(1):99. PubMed ID: 34098977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
    Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of CT-guided (125)I seed brachytherapy for postoperative locoregional recurrence in patients with non-small cell lung cancer.
    Huo X; Wang H; Yang J; Li X; Yan W; Huo B; Zheng G; Chai S; Wang J; Guan Z; Yu Z
    Brachytherapy; 2016; 15(3):370-380. PubMed ID: 26944267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
    Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy.
    Yao L; Jiang Y; Jiang P; Wang H; Meng N; Qu A; Tian S; Sun H; Liu C; Wang J; Zhang K
    Brachytherapy; 2015; 14(5):662-9. PubMed ID: 26138110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
    Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial Experience with CT-Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases.
    Schippers AC; Collettini F; Steffen IG; Wieners G; Denecke T; Pavel M; Wust P; Gebauer B
    J Vasc Interv Radiol; 2017 May; 28(5):672-682. PubMed ID: 27645463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases].
    Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Lopez Hänninen E; Felix R
    Strahlenther Onkol; 2004 May; 180(5):274-80. PubMed ID: 15127157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors : A systematic analysis of 102 cases.
    Powerski M; Penzlin S; Hass P; Seidensticker R; Mohnike K; Damm R; Steffen I; Pech M; Gademann G; Ricke J; Seidensticker M
    Strahlenther Onkol; 2019 Mar; 195(3):265-273. PubMed ID: 30470846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
    Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
    Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy - a phase II-study.
    Wieners G; Mohnike K; Peters N; Bischoff J; Kleine-Tebbe A; Seidensticker R; Seidensticker M; Gademann G; Wust P; Pech M; Ricke J
    Radiother Oncol; 2011 Aug; 100(2):314-9. PubMed ID: 21497930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study.
    Tselis N; Chatzikonstantinou G; Kolotas C; Milickovic N; Baltas D; Zamboglou N
    Eur Radiol; 2013 Aug; 23(8):2264-70. PubMed ID: 23515917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient template-guided permanent interstitial brachytherapy using
    Feddock J; Aryal P; Steber C; Edwards J; Cheek D; Randall M
    Brachytherapy; 2017; 16(2):393-401. PubMed ID: 28139423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
    Umezawa R; Murakami N; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Takahashi K; Inaba K; Ito Y; Igaki H; Masui K; Yoshida K; Jingu K; Tselis N; Itami J
    Brachytherapy; 2018; 17(2):368-376. PubMed ID: 29275869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
    Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
    Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.
    Huang K; D'Souza D; Patil N; Velker V; Leung E; Stitt L; Whiston F; Sugimoto A; McGee J; Prefontaine M
    Brachytherapy; 2016; 15(5):543-8. PubMed ID: 27475479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
    Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodules.
    Heinze C; Damm R; Othmer M; Thormann M; Surov A; Hass P; Seidesticker R; Seidensticker M; Ricke J; Powerski M; Pech M; Omari J
    Brachytherapy; 2023; 22(2):231-241. PubMed ID: 36697267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates].
    Collettini F; Schnapauff D; Poellinger A; Denecke T; Banzer J; Golenia MJ; Wust P; Gebauer B
    Rofo; 2012 Apr; 184(4):316-23. PubMed ID: 22297915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.